May 11, 2026 07:54AM
May 11, 2026 07:30AM
Feb 26, 2026 01:31PM
Feb 26, 2026 07:35AM
Feb 26, 2026 07:30AM
Feb 19, 2026 07:30AM
Nov 6, 2025 04:29PM Intellia Therapeutics (NTLA) Tops Q3 EPS by 9c
Nov 6, 2025 04:00PM
Oct 28, 2025 04:23AM
Aug 8, 2025 06:24AM
Aug 7, 2025 07:33AM
Aug 7, 2025 07:30AM
Jul 31, 2025 07:30AM
May 8, 2025 07:31AM Intellia Therapeutics (NTLA) Tops Q1 EPS by 17c
May 8, 2025 07:30AM
May 1, 2025 07:30AM
Feb 27, 2025 03:04PM
Feb 27, 2025 07:30AM
Feb 27, 2025 07:30AM
Feb 20, 2025 07:30AM
Nov 11, 2024 07:52AM Intellia Therapeutics (NTLA) PT Lowered to $60 at Oppenheimer
Nov 7, 2024 08:21AM
Nov 7, 2024 07:30AM
Oct 31, 2024 07:30AM
Oct 7, 2024 07:31AM
Oct 7, 2024 07:30AM
Aug 8, 2024 07:30AM
Aug 8, 2024 07:30AM Intellia Therapeutics Announces Second Quarter 2024 Financial Results and Highlights Recent Company Progress
Aug 1, 2024 07:30AM
May 9, 2024 07:37AM
May 9, 2024 07:30AM
May 2, 2024 07:30AM
Feb 23, 2024 09:23AM
Feb 22, 2024 07:37AM
Feb 22, 2024 07:30AM Intellia Therapeutics Announces Fourth Quarter and Full-Year 2023 Financial Results and Highlights Recent Company Progress
Feb 14, 2024 07:30AM
Nov 9, 2023 07:31AM
Nov 9, 2023 07:30AM
Oct 26, 2023 07:30AM
Oct 18, 2023 07:02AM
Oct 18, 2023 07:00AM
Aug 3, 2023 07:34AM Intellia Therapeutics (NTLA) Misses Q2 EPS by 8c, beats revenue
Aug 3, 2023 07:30AM
Jul 27, 2023 07:30AM
May 4, 2023 08:19AM
May 4, 2023 07:30AM
Apr 27, 2023 07:30AM
Feb 23, 2023 07:49AM
Feb 23, 2023 07:30AM Intellia Therapeutics Announces Fourth Quarter and Full-Year 2022 Financial Results and Highlights Recent Company Progress
Feb 16, 2023 07:30AM

1,197,273 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All